Microcap Ledger Quanterix Corp $QTRX
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- Nasdaq Global Market
- Sector
- Laboratory Analytical Instruments
- Headquarters
- Billerica, MA
- Fiscal year end
- December 31
- Shares outstanding
- 47,293,065 [10-Q 2026-08-10]
What the company doesAI summary of filing
Quanterix is a life sciences company that develops and sells ultra-sensitive protein detection instruments, consumables, and services for biomarker research and diagnostics. The company offers two main technology platforms: Simoa, a digital immunoassay technology that detects proteins at extremely low concentrations in blood and other fluids, and Spatial Biology platforms that analyze multiple protein biomarkers within intact tissue samples at single-cell resolution. Quanterix generates revenue by selling instruments (HD-X, SR-X, SP-X, and Spatial Biology platforms) and assay kits to research laboratories, academic institutions, contract research organizations, and biopharmaceutical companies worldwide, as well as providing contract research services and clinical laboratory testing services through its CLIA-certified Accelerator Laboratory. The company is revenue-generating, with recent acquisitions of Akoya Biosciences and Emission, Inc. that expand its spatial biology capabilities and manufacturing capacity. [10-K 2026-03-02]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $69.32M | −$66.47M | −$23.23M | $44.17M | [10-Q 2026-08-10] |
| FY ended Dec 2025 | $138.90M | −$107.20M | −$77.24M | $29.84M | [10-K 2026-03-02] |
| FY ended Dec 2024 | $137.42M | −$38.50M | −$35.16M | $56.71M | [10-K 2026-03-02] |
- Quarterly cash burn
- −$11.61M
- Cash runway Estimate
- ~11.4 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-12-17 | 38,524,326 | [10-Q 2024-12-26] |
| 2025-03-11 | 38,776,208 | [10-K/A 2025-04-30] |
| 2025-05-06 | 38,829,386 | [10-Q 2025-05-12] |
| 2025-07-31 | 46,465,915 | [10-Q 2025-08-07] |
| 2025-11-04 | 46,710,797 | [10-Q 2025-11-10] |
| 2026-02-23 | 46,939,975 | [10-K 2026-03-02] |
| 2026-04-30 | 47,105,981 | [10-Q 2026-05-06] |
| 2026-08-03 | 47,293,065 | [10-Q 2026-08-10] |
Listing status
Current status: 1 Form 8-K Item 3.01 filing(s) in the last 24 months, most recent 2024-11-22. Item 3.01 covers delisting notices, failures to meet a listing rule and listing transfers; read the filing for which one.
| Date | Event | Details | Deadline | Filing |
|---|---|---|---|---|
| 2024-11-22 | 8-K Item 3.01 | Notice of delisting or failure to satisfy a continued listing rule or standard; or transfer of listing | — | [8-K 2024-11-22] |
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-10-02 | Magovcevic-Liebisch Ivana | exercise | 4,224 | — | [4 2026-10-02] |
| 2026-10-01 | Mendel Scott | grant | 4,398 | $3.41 | [4 2026-10-02] |
| 2026-10-01 | Donnelly William P | grant | 6,964 | $3.41 | [4 2026-10-02] |
| 2026-09-15 | Miller Michael Francis | exercise | 81 | — | [4 2026-09-16] |
| 2026-09-15 | Miller Michael Francis | other | 25 | $2.72 | [4 2026-09-16] |
| 2026-09-15 | Miller Michael Francis | exercise | 136 | — | [4 2026-09-16] |
| 2026-09-15 | Miller Michael Francis | other | 41 | $2.72 | [4 2026-09-16] |
| 2026-09-15 | Miller Michael Francis | exercise | 135 | — | [4 2026-09-16] |
| 2026-09-15 | Miller Michael Francis | other | 41 | $2.72 | [4 2026-09-16] |
| 2026-09-15 | Miller Michael Francis | exercise | 372 | — | [4 2026-09-16] |
| 2026-09-15 | Miller Michael Francis | other | 111 | $2.72 | [4 2026-09-16] |
| 2026-09-15 | Miller Michael Francis | exercise | 834 | — | [4 2026-09-16] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-14 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-08-10 | 10-Q | Quarterly report |
| 2026-08-10 | 8-K | Results of operations; Regulation FD disclosure |
| 2026-08-06 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-06-10 | 8-K | Shareholder vote results |
| 2026-06-09 | 8-K | Director or officer change; Regulation FD disclosure |
| 2026-05-26 | 8-K | Director or officer change |
| 2026-05-15 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-15 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-12 | 8-K | Director or officer change; Regulation FD disclosure |
| 2026-05-07 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-06 | 10-Q | Quarterly report |
Alerts for $QTRX
Email me when Quanterix Corp files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.